ARS Pharma
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
11682 El Camino Real Ste 300, San Diego,...Phone Number
(858) 771-9307Website
www.ars-pharma.comRevenue
$99 MillionStock Symbol
SPRYIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About ARS Pharma
ARS Pharm operates as a pharmaceutical company. The Company develops an intranasal epinephrine spray with a unique absorption technology to save patients from allergic reactions of food, medications, and insect bites. Established in 2015, ARS Pharm is headquartered in San Diego, California, United States.Explore more
ARS Pharma Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ARS Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ARS Pharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ARS Pharma
Check out if ARS Pharma is spiking on competitors!
Funding: Get notified immidiatlly once ARS Pharma has new funding data
Website visits: Recent activity has been detected on your website
Check if ARS Pharma has recently received funding, and reach out quickly before it becomes old news!
ARS Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when ARS Pharma launches new products
Click to see if ARS Pharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to ARS Pharma
Compare insights from companies similar to ARS Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ARS Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ARS Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ARS Pharma.
ARS Pharma financials insights
Gather financial insights about ARS Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series C
$20M
2021
Series D
$55M
ARS Pharma Tech Stack
A closer look at the technologies used by ARS Pharma
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Promotion
Executive Move
Donn Casale, President, has assumed the additional role of Chief Executive Officer & Board Director.
Executive Moves, Promotion, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Business Finance, Finance, Financial Operations
Person-Based
Advertising
ARS Pharma News & Media
SPRY DEADLINE: The Gross Law Firm Reminds ARS Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline
NEW YORK, Aug. 11, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY). Shareholders who purchased shares of SPRY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff...SPRY Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ARS Pharmaceuticals Inc. Securities Class Action
Robbins LLP is Investigating Allegations that ARS Pharmaceuticals Misled Investors Regarding Their Business ProspectsSPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Aug. 10, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ARS Pharmaceuticals, Inc. ("ARS" or "the Company") (NASDAQ: SPRY) for violations of §§10(b) and 20(a) of the...ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
LOS ANGELES, Aug. 10, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against ARS Pharmaceuticals, Inc. ("ARS" or "the Company") (NASDAQ: SPRY) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ARS Pharma
Sign Up For FreeTo access detailed company insights
ARS Pharm operates as a pharmaceutical company. The Company develops an intranasal epinephrine spray with a unique absorption technology to save patients from allergic reactions of food, medications, and insect bites. Established in 2015, ARS Pharm is headquartered in San Diego, California, United States.... Read More
